Article
Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET.
Japanese journal of radiology - 1 Nov 2023
Wang Yang, Fushimi Yasutaka, Arakawa Yoshiki, Shimizu Yoichi, Sano Kohei, Sakata Akihiko, Nakajima Satoshi, Okuchi Sachi, Hinoda Takuya, Oshima Sonoko, Otani Sayo, Ishimori Takayoshi, Tanji Masahiro, Mineharu Yohei, Yoshida Kazumichi, Nakamoto Yuji
Abstract excerpt
PURPOSE: This study aimed to investigate the uptake characteristics of 18F-fluoromisonidazole (FMISO), in mutant-type isocitrate dehydrogenase (IDH-mutant, grade 3 and 4) and wild-type IDH (IDH-wildtype, grade 4) 2021 WHO classification adult-type diffuse gliomas. MATERIALS AND METHODS: Patients with grade 3 and 4 adult-type diffuse gliomas (n = 35) were included in this prospective study. After registering...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.